The story of the inhibition of BCR-ABL as a treatment for chronic myelogenous leukaemia serves to illustrate key aspects of the kinase drug discovery and development process. Firstly, elucidation of the disease mechanism enabled identification of the molecular target(s) which catalysed pharmaceutical research and resulted in Gleevec(®) (Novartis) as the first FDA approved BCR-ABL inhibitor. However, clinical success was soon tempered by the emergence of drug resistance through various mechanisms. Using rational drug design, several hypotheses were devised to overcome resistance issues leading to the development of second generation inhibitors, providing clinicians and patients with greater therapeutic choice.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Lamontanara AJ, Gencer EB, Kuzyk O, Hantschel O. Lamontanara AJ, et al. Biochim Biophys Acta. 2013 Jul;1834(7):1449-59. doi: 10.1016/j.bbapap.2012.12.009. Epub 2012 Dec 28. Biochim Biophys Acta. 2013. PMID: 23277196 Review.
Asaki T, Sugiyama Y, Hamamoto T, Higashioka M, Umehara M, Naito H, Niwa T. Asaki T, et al. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1421-5. doi: 10.1016/j.bmcl.2005.11.042. Epub 2005 Dec 5. Bioorg Med Chem Lett. 2006. PMID: 16332440
Weisberg E, Manley PW, Cowan-Jacob SW, Hochhaus A, Griffin JD. Weisberg E, et al. Nat Rev Cancer. 2007 May;7(5):345-56. doi: 10.1038/nrc2126. Nat Rev Cancer. 2007. PMID: 17457302 Review.
Schenone S, Bruno O, Radi M, Botta M. Schenone S, et al. Med Res Rev. 2011 Jan;31(1):1-41. doi: 10.1002/med.20175. Med Res Rev. 2011. PMID: 19714578 Review.
Yun SM, Jung KH, Kim SJ, Fang Z, Son MK, Yan HH, Lee H, Kim J, Shin S, Hong S, Hong SS. Yun SM, et al. Cancer Lett. 2014 Jun 28;348(1-2):50-60. doi: 10.1016/j.canlet.2014.03.012. Epub 2014 Mar 18. Cancer Lett. 2014. PMID: 24657654
Gach-Janczak K, Drogosz-Stachowicz J, Janecka A, Wtorek K, Mirowski M. Gach-Janczak K, et al. Cancers (Basel). 2024 May 15;16(10):1878. doi: 10.3390/cancers16101878. Cancers (Basel). 2024. PMID: 38791957 Free PMC article. Review.
Spassov DS, Atanasova M, Doytchinova I. Spassov DS, et al. Int J Mol Sci. 2024 Mar 13;25(6):3249. doi: 10.3390/ijms25063249. Int J Mol Sci. 2024. PMID: 38542228 Free PMC article.
Dolgoy N, Bernard S, Huang F, Driga A, Hall-Lavoie D, Brown A, Pituskin E, Fairchild A, McNeely ML. Dolgoy N, et al. Res Involv Engagem. 2024 Mar 25;10(1):35. doi: 10.1186/s40900-024-00566-2. Res Involv Engagem. 2024. PMID: 38528573 Free PMC article.
Hoemberger M, Pitsawong W, Kern D. Hoemberger M, et al. Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19221-19227. doi: 10.1073/pnas.1919221117. Epub 2020 Jul 27. Proc Natl Acad Sci U S A. 2020. PMID: 32719139 Free PMC article.
Singh AP, Umbarkar P, Tousif S, Lal H. Singh AP, et al. Int J Cardiol. 2020 Oct 1;316:214-221. doi: 10.1016/j.ijcard.2020.05.077. Epub 2020 May 27. Int J Cardiol. 2020. PMID: 32470534 Free PMC article. Review.